HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,204,493 | +66.7% | 13,446 | +58.4% | 0.01% | +66.7% |
Q2 2023 | $722,583 | +8.9% | 8,487 | +5.8% | 0.00% | 0.0% |
Q1 2023 | $663,821 | +20.8% | 8,022 | +14.8% | 0.00% | 0.0% |
Q4 2022 | $549,606 | +14.3% | 6,988 | +7.5% | 0.00% | 0.0% |
Q3 2022 | $481,000 | +13.4% | 6,503 | 0.0% | 0.00% | +50.0% |
Q2 2022 | $424,000 | -4.9% | 6,503 | -7.8% | 0.00% | 0.0% |
Q1 2022 | $446,000 | +19.3% | 7,051 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $374,000 | +3.9% | 7,051 | +38.1% | 0.00% | 0.0% |
Q3 2021 | $360,000 | +25.0% | 5,106 | +18.3% | 0.00% | 0.0% |
Q2 2021 | $288,000 | -47.3% | 4,316 | -12.3% | 0.00% | -33.3% |
Q1 2021 | $546,000 | -27.8% | 4,921 | -22.7% | 0.00% | -40.0% |
Q4 2020 | $756,000 | +53.7% | 6,364 | +12.8% | 0.01% | +66.7% |
Q3 2020 | $492,000 | -2.6% | 5,643 | 0.0% | 0.00% | -25.0% |
Q2 2020 | $505,000 | +22.3% | 5,643 | +36.0% | 0.00% | 0.0% |
Q1 2020 | $413,000 | +2.5% | 4,148 | +18.3% | 0.00% | +33.3% |
Q4 2019 | $403,000 | -8.8% | 3,505 | 0.0% | 0.00% | -25.0% |
Q3 2019 | $442,000 | +9.7% | 3,505 | +4.8% | 0.00% | +33.3% |
Q2 2019 | $403,000 | +37.5% | 3,346 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $293,000 | -60.8% | 3,346 | -55.2% | 0.00% | -62.5% |
Q4 2018 | $747,000 | -12.6% | 7,462 | 0.0% | 0.01% | +14.3% |
Q3 2018 | $855,000 | -11.6% | 7,462 | -30.8% | 0.01% | -22.2% |
Q2 2018 | $967,000 | +8.9% | 10,783 | -11.1% | 0.01% | +12.5% |
Q1 2018 | $888,000 | +26.0% | 12,132 | 0.0% | 0.01% | +33.3% |
Q4 2017 | $705,000 | +81.7% | 12,132 | +40.3% | 0.01% | +50.0% |
Q3 2017 | $388,000 | +506.2% | 8,649 | +430.0% | 0.00% | +300.0% |
Q2 2017 | $64,000 | +12.3% | 1,632 | +16.8% | 0.00% | 0.0% |
Q1 2017 | $57,000 | +1.8% | 1,397 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $56,000 | +9.8% | 1,397 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $51,000 | +50.0% | 1,397 | +19.0% | 0.00% | – |
Q2 2016 | $34,000 | -17.1% | 1,174 | 0.0% | 0.00% | -100.0% |
Q1 2016 | $41,000 | +7.9% | 1,174 | 0.0% | 0.00% | – |
Q4 2015 | $38,000 | +123.5% | 1,174 | +129.3% | 0.00% | – |
Q3 2015 | $17,000 | +54.5% | 512 | +95.4% | 0.00% | – |
Q2 2015 | $11,000 | -8.3% | 262 | 0.0% | 0.00% | – |
Q1 2015 | $12,000 | -98.8% | 262 | -99.1% | 0.00% | -100.0% |
Q1 2014 | $978,000 | -88.3% | 30,000 | -85.7% | 0.03% | -89.7% |
Q3 2013 | $8,389,000 | +6.0% | 210,360 | +9.9% | 0.29% | +4.7% |
Q2 2013 | $7,917,000 | +12.1% | 191,460 | +13.0% | 0.28% | +11.7% |
Q1 2013 | $7,060,000 | +25.4% | 169,460 | +22.9% | 0.25% | +12.2% |
Q4 2012 | $5,629,000 | – | 137,830 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |